1. Home
  2. TRBG vs LNSR Comparison

TRBG vs LNSR Comparison

Compare TRBG & LNSR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

TRBG

TurboGen Ltd. Ordinary Shares

N/A

Current Price

$3.51

Market Cap

87.2M

Sector

Utilities

ML Signal

N/A

Logo LENSAR Inc.

LNSR

LENSAR Inc.

HOLD

Current Price

$6.04

Market Cap

75.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TRBG
LNSR
Founded
2014
2004
Country
Israel
United States
Employees
20
N/A
Industry
Power Generation
Medical Electronics
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
87.2M
75.1M
IPO Year
N/A
2005

Fundamental Metrics

Financial Performance
Metric
TRBG
LNSR
Price
$3.51
$6.04
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
★ $11.33
AVG Volume (30 Days)
★ 48.6K
34.2K
Earning Date
09-24-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
N/A
★ 0.61
Revenue
N/A
★ $58,435,000.00
Revenue This Year
N/A
$4.90
Revenue Next Year
N/A
$18.71
P/E Ratio
★ N/A
$9.34
Revenue Growth
N/A
★ 9.24
52 Week Low
$3.13
$4.95
52 Week High
$5.84
$12.94

Technical Indicators

Market Signals
Indicator
TRBG
LNSR
Relative Strength Index (RSI) 37.00 37.96
Support Level $3.50 $5.34
Resistance Level $3.78 $6.20
Average True Range (ATR) 0.23 0.20
MACD 0.06 -0.02
Stochastic Oscillator 43.93 31.60

Price Performance

Historical Comparison
TRBG
LNSR

About TRBG TurboGen Ltd. Ordinary Shares

Turbogen Ltd is engaged in developing multifuel CHP systems with a vision of providing on-site energy for buildings. Its CHP systems outperform current electric efficiency solutions, enabling fast ROI, lower building emissions, and peak saving for utilities. The company's multi-fuel technology enables hybrid Operations: Solar-Gas, Hydrogen-Gas, SOFC-Gas.

About LNSR LENSAR Inc.

LENSAR Inc is a commercial-stage medical device company focused on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, simplified procedure planning, efficient design, and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia (excluding South Korea), South Korea, and Other.

Share on Social Networks: